Skip to main content

Inkef — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

48
Companies
$996.0M
Total invested
$25.5M
Avg. check
53
Industries
Biotechnology 11Health Care 7Therapeutics 6Pharmaceutical 5Artificial Intelligence (AI) 5Medical 5+47 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 48
TargED Biopharmaceuticals
December 2025

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

Biopharma · Utrecht$25.3M Series A
Salvia BioElectronics
May 2025

Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.

Biotechnology · Eindhoven$60.1M Series B
Draupnir Bio
July 2024

Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.

Biotechnology · Risskov$13.2M Seed
Provable Markets
May 2024

Provable Markets provides a secure platform for cash and synthetic equity finance trading through its ATS, Aurora.

Finance · New York$8.0M Series A
Aito
June 2023

Aito develops configurable touch-interface chips using Software Enhanced Piezo (SEP) for overlays on glass, metal, plastic, wood, or fabric.

Automotive · Amsterdam$6.5M Series Unknown
Anavo Therapeutics
May 2023

Anavo Therapeutics provides therapeutic potential of human phosphatase biology.

Biotechnology · Leiden$9.4M Seed
Precirix
March 2022

Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.

Biotechnology · Brussels$88.2M Series B
Scenic Biotech
March 2022

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.

Biometrics · Amsterdam$31.0M Series A
Sentinels
September 2021

Sentinels is an AI-powered transaction monitoring startup.

Artificial Intelligence (AI) · AmsterdamCorporate Round
Calypso Biotech
September 2021

Calypso Biotech is a biotechnology company that developes therapeutics for autoimmune diseases.

Biotechnology · Plan-les-ouates$9.5M Series A
EclecticIQ
August 2021

EclecticIQ offers threat intelligence, hunting, response technology, and services.

Artificial Intelligence (AI) · Amsterdam$3.5M Series Unknown
Castor
July 2021

Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.

Clinical Trials · Amsterdam$45.0M Series B
Comet Therapeutics
June 2019

Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.

Biotechnology · Cambridge$28.5M Series A
Bloomon
March 2019

Bloomon is a rapidly growing e-commerce start-up.

E-Commerce · Amsterdam$8.4M Series C
Withlocals
March 2019

Withlocals is the peer-to-peer marketplace where local people offer experiences and their skills to travelers.

Leisure · Eindhoven$9.0M Series B
Aidence
February 2019

Aidence provides AI solutions for the lung cancer pathway.

Artificial Intelligence (AI) · Amsterdam$11.3M Series A
GeoPhy
January 2019

GeoPhy uses data science to provide the real estate industry with an objective understanding of value.

Analytics · The Hague$33.0M Series B
Polarsteps
January 2019

One travel app for all your adventures

Mobile · Amsterdam$3.4M Series A
Rainier Therapeutics
May 2018

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

Biopharma · San Leandro$20.0M Series B
OneFit
May 2018

OneFit is a fitness aggregator, giving its users access to a multitude of different gyms and studios through a single monthly membership

Fitness · Amsterdam$5.1M Series A
Health Value Creation
December 2017

Health Value Creation is developing two surgical devices, a diagnostic tool and a trocar closure device.

Biotechnology · Maastricht$2.4M Series A
Crowdynews
February 2016

Crowdynews offers an AI-driven content curation platform that helps publishers and brands increase visitor engagement, conversion & revenue.

Artificial Intelligence (AI) · Groningen$4.2M Series A
Wercker
January 2016

Wercker is a platform and tool to rapidly develop, build, and deploy containerized applications and microservices for the modern cloud.

Cloud Computing · Amsterdam$4.5M Series A
Lanthio Pharma
May 2014

Lanthio Pharma is focused on the research and development of therapeutic lantipeptide drugs for serious diseases.

Biotechnology · Groningen$4.9M Debt Financing

Where Inkef invests

Biotechnology11
Health Care7
Therapeutics6
Pharmaceutical5
Artificial Intelligence (AI)5
Medical5

About Inkef's portfolio

How many companies has Inkef invested in?

Inkef has invested in 48 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Inkef invest in?

Inkef's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Artificial Intelligence (AI). The firm invests across 53 different industry categories.

What is Inkef's largest investment?

Among tracked funding rounds, Precirix received $88.2M in a Series B round. Inkef's total known invested capital is $996.0M.

What is the average investment size for Inkef?

Inkef's average investment size is $25.5M across its portfolio of 48 companies.

What are Inkef's most recent investments?

Recent Inkef portfolio additions include TargED Biopharmaceuticals, Salvia BioElectronics, Draupnir Bio, Provable Markets, Aito. These companies were founded in 2020 or later.

Reach the founders behind these 48 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →